Preparation method of cefoperazone
By dropping HO-EPCP acid chloride into the 7-TMCA solution under low temperature conditions and performing post-treatment steps, the content of impurity H in cefoperazone was successfully reduced, the problem of high impurity H content in the prior art was solved, and the Preparation of cefoperazone with high purity and high yield.
Patent Information
- Application Number
- CN202410985211.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-22
AI Technical Summary
In the existing preparation methods for cefoperazone, the content of impurity H is relatively high, which is difficult to reduce to less than 0.15%, affecting the quality of cefoperazone sodium product.
The HO-EPCP acid chloride solution was added dropwise to the 7-TMCA solution at -30 to -20°C, and the molar ratio was controlled within the range of 1: (1.05 to 1.15). Combined with post-treatment steps such as adding purified water, activated carbon and heavy weight. Sodium sulfite was decolorized and washed, followed by crystallization by filtrate with water and dried in vacuo to obtain cefoperazone.
It effectively reduces the content of impurity H in cefoperazone, making it less than 0.15%, the yield of cefoperazone reaches more than 90%, and the purity reaches more than 99.6%, which meets the quality standards of cefoperazone sodium raw materials.
Smart Images

Figure CN118930559A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicines, and particularly relates to a method for preparing cefoperazone. Background Art
[0002] Cefoperazone sodium is a third-generation cephalosporin antibiotic with a broad-spectrum antibacterial effect and can be used to treat a variety of bacterial infections. Cefoperazone is an important intermediate of cefoperazone sodium API, and its chemical structure is as follows:
[0003] The existing cefoperazone is mainly prepared by 7-TMCA (cefmenoxime nucleus,
[0004] ) and HO-EPCP chloride Reaction generated.
[0005] The latest quality standards for cefoperazone sodium raw materials of pharmaceutical companies have set stricter limits on the content of known impurities that may exist in cefoperazone sodium products, the content of other total impurities except known impurities, and the content of other single impurities except known impurities. Experiments have shown that the most difficult to control is the content of other single impurities except known impurities. The internal release standards of pharmaceutical companies require that the content of other single impurities in cefoperazone sodium be less than or equal to 0.1%, and the content of other single impurities in the intermediate cefoperazone be less than or equal to 0.15%.
[0006] According to the high performance liquid chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0512), the impurity peak area of cefoperazone and cefoperazone sodium at a relative retention time of 1.18 (RRT = 1.18) is large, which is the main factor affecting the quality of cefoperazone sodium products. The impurity with RRT = 1.18 (marked as impurity H) was structurally confirmed, and the structural formula of impurity H is as follows:
[0007] Impurity H
[0008] It can be seen that impurity H comes from cefoperazone, and reducing the content of impurity H in cefoperazone is the key to reducing the content of impurity H in cefoperazone sodium. According to the statistics of relevant experimental results, when cefoperazone sodium is generated from cefoperazone, impurity H will be reduced by about 50%. If cefoperazone sodium is required to meet the requirements of other single impurities being less than or equal to 0.1%, the content of impurity H in cefoperazone must be less than or equal to 0.15%. The existing 7-TMCA and HO-EPCP acyl chloride are used to prepare cefoperazone, and the content of impurity H is higher than 0.3%. Since the content of impurity H itself is low (less than 0.8%), it is difficult to reduce the content of impurity H to less than 0.15% even through post-treatment process while ensuring the yield of cefoperazone. Therefore, it is necessary to develop a method for preparing cefoperazone that can effectively reduce the content of impurity H. Summary of the invention
[0009] The object of the present invention is to provide a method for preparing cefoperazone which can effectively reduce the content of impurity H.
[0010] In order to solve the above technical problems, the present invention adopts the following technical solutions:
[0011] A method for preparing cefoperazone, comprising:
[0012] Providing 7-TMCA solution;
[0013] Providing HO-EPCP acyl chloride solution;
[0014] At -30 to -20°C, the HO-EPCP acyl chloride solution is added dropwise to the 7-TMCA solution. After the addition is complete, the mixture is kept warm at -30 to -20°C to obtain a reaction solution containing cefoperazone.
[0015] Preferably, the molar ratio of 7-TMCA in the 7-TMCA solution to HO-EPCP in the HO-EPCP acyl chloride solution is 1:(1.05-1.15).
[0016] Further preferably, the molar ratio of 7-TMCA in the 7-TMCA solution to HO-EPCP in the HO-EPCP acyl chloride solution is 1:(1.05-1.1).
[0017] Still more preferably, the molar ratio of 7-TMCA in the 7-TMCA solution to HO-EPCP in the HO-EPCP acyl chloride solution is 1:(1.05-1.08).
[0018] According to some embodiments, the preparation method of the HO-EPCP acyl chloride solution is: adding phosphorus oxychloride to a solution consisting of HO-EPCP, N,N-dimethylacetamide and acetonitrile at -30 to -20°C, and continuing to heat and react at -30 to -20°C to obtain the HO-EPCP acyl chloride solution.
[0019] Preferably, the molar ratio of HO-EPCP to phosphorus oxychloride is 1:(1.05-1.10).
[0020] More preferably, the molar ratio of HO-EPCP to phosphorus oxychloride is 1:(1.05-1.07).
[0021] Preferably, the mass ratio of the HO-EPCP to N,N-dimethylacetamide and acetonitrile is 1:(2-5):(2-5).
[0022] Further preferably, the mass ratio of the HO-EPCP to N,N-dimethylacetamide and acetonitrile is 1:(4-5):(3-4).
[0023] More preferably, the mass ratio of the HO-EPCP to N,N-dimethylacetamide and acetonitrile is 1:(4.5-5):(3.5-4).
[0024] Preferably, in the method for preparing the HO-EPCP acyl chloride solution, the insulation reaction time is 0.4 to 0.6 h.
[0025] According to some embodiments, the 7-TMCA solution is prepared by mixing 7-TMCA, acetonitrile and N,O-bistrimethylsilylacetamide.
[0026] Preferably, the molar ratio of 7-TMCA to N,O-bistrimethylsilylacetamide in the 7-TMCA solution is 1:(1.1-1.5).
[0027] Further preferably, the molar ratio of 7-TMCA to N,O-bistrimethylsilylacetamide in the 7-TMCA solution is 1:(1.1-1.2).
[0028] Preferably, the mass ratio of 7-TMCA to acetonitrile in the 7-TMCA solution is 1:(4-8).
[0029] Further preferably, the mass ratio of 7-TMCA to acetonitrile in the 7-TMCA solution is 1:(4-5).
[0030] Preferably, the insulation reaction time of the HO-EPCP acyl chloride solution and the 7-TMCA solution is 1.5 to 2.5 hours.
[0031] More preferably, the insulation reaction time of the HO-EPCP acyl chloride solution and the 7-TMCA solution is 1.8 to 2.2 hours.
[0032] Preferably, the preparation method of cefoperazone further comprises post-treatment, which comprises: first adding purified water, activated carbon and sodium metabisulfite to the reaction solution containing cefoperazone for decolorization, then filtering, washing with a mixture of acetonitrile and purified water, adding water to the filtrate for crystallization, growing crystals, separating solids, and vacuum drying the solids to obtain cefoperazone.
[0033] Preferably, the method for preparing cefoperazone further comprises the step of preparing 7-TMCA by reacting 1-methyl-5-mercapto-1,2,3,4-tetrazolyl and 7-ACA in boron trifluoride acetonitrile at 25-35° C. under inert gas protection.
[0034] In some embodiments, the reaction time at 25-35°C is 1-2h. After the reaction is completed, the temperature is lowered to 0-5°C, purified water is added and the pH is adjusted to 3.0-4.0, and crystallization is stirred at 0-5°C, filtered, and the filter cake is washed with purified water and acetone in turn, and dried to obtain the 7-TMCA.
[0035] Compared with the prior art, the present invention has the following advantages:
[0036] The preparation method of cefoperazone of the present invention can effectively reduce the content of impurity H in cefoperazone. Experiments have confirmed that the content of impurity H in cefoperazone can be reduced to less than 0.15%, and the yield of cefoperazone reaches more than 90%, the purity reaches more than 99.6%, and the contents of other impurities are all less than 0.15%. Therefore, the cefoperazone prepared by the method of the present invention can prepare cefoperazone sodium that fully meets the quality standards of cefoperazone sodium raw material medicine. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 is the HPLC spectrum of cefoperazone of Example 1;
[0038] Figure 2 is the HPLC spectrum of cefoperazone of Example 2;
[0039] Figure 3 is the HPLC spectrum of cefoperazone of Example 3;
[0040] Figure 4 is the HPLC spectrum of cefoperazone of Example 4;
[0041] Figure 5 The HPLC spectrum of cefoperazone of Comparative Example 1;
[0042] Figure 6 The HPLC spectrum of cefoperazone of Comparative Example 2 is shown in FIG.
[0043] Figure 7 For impurity H 1 H-NMR spectrum;
[0044] Figure 8 This is the MS spectrum of impurity H. DETAILED DESCRIPTION
[0045] The present invention is further described below in conjunction with the examples. However, the present invention is not limited to the following examples. The implementation conditions used in the examples can be further adjusted according to the different requirements of specific use, and the implementation conditions not specified are conventional conditions in the industry. The technical features involved in each embodiment of the present invention can be combined with each other as long as they do not conflict with each other.
[0046] The applicant prepared cefoperazone as an important intermediate of cefoperazone sodium according to the prior art, and the impurity H in the cefoperazone sodium formed by the reaction was confirmed to have the structural formula of:
[0047] Impurity H
[0048] The 1H-NMR spectrum of impurity H is shown in Figure 7 , MS spectrum see Figure 8 According to the structural confirmation, impurity H is produced in the process of mixed reaction of HO-EPCP acyl chloride and 7-TMCA. After a series of experimental results, the impurity H will be reduced by about 50% when cefoperazone is produced into cefoperazone sodium. Therefore, if the content of impurity H in cefoperazone sodium is controlled within 0.1%, the content of impurity H in cefoperazone must be controlled within 0.15%.
[0049] In order to reduce the content of impurity H, the applicant has conducted a lot of research and unexpectedly found that in the process of mixing HO-EPCP acyl chloride and 7-TMCA, the method of adding HO-EPCP acyl chloride solution to 7-TMCA solution can further reduce the content of impurity H in the product. Combined with other experimental operations, the content of impurity H in cefoperazone was successfully controlled within 0.15%.
[0050] Specifically, based on a large amount of experimental data combined with the structure of impurity H, the inventors of the present application speculate that impurity H is an amide impurity formed by the reaction of cefoperazone acyl chloride with the amino group of 7-TMCA, and the reaction process is that HO-EPCP acyl chloride reacts with 7-TMCA to generate cefoperazone, cefoperazone reacts with phosphorus oxychloride remaining in the reaction solution (when preparing HO-EPCP acyl chloride solution, it is difficult to ensure that HO-EPCP and phosphorus oxychloride react completely, and in order to improve the yield of HO-EPCP acyl chloride, phosphorus oxychloride is usually slightly excessive) to generate cefoperazone acyl chloride, and cefoperazone acyl chloride reacts with 7-TMCA to generate impurity H. If the HO-EPCP acyl chloride solution and the 7-TMCA solution are directly mixed and reacted, the exothermic reaction is difficult to control and a lot of impurities will be generated; if the 7-TMCA solution is added dropwise to the HO-EPCP acyl chloride solution, then in the early stage of the reaction, the cefoperazone and HO-EPCP generated in the reaction system can both react with phosphorus oxychloride to generate corresponding acyl chlorides, resulting in competition, and impurity H is inevitably generated. When the HO-EPCP chloride solution is added dropwise to the 7-TMCA solution, in the early stage of the reaction, the concentration of phosphorus oxychloride in the reaction system is significantly lower than that of directly mixing the HO-EPCP chloride solution and the 7-TMCA solution or adding the 7-TMCA solution dropwise to the HO-EPCP chloride solution. During the competitive reaction, less cefoperazone chloride is formed, and the amount of impurity H generated by the continued reaction with 7-TMCA is even less. Further, in conjunction with the optimization of other reaction operations, the content of impurity H in cefoperazone is successfully reduced to less than 0.15%, and the yield of cefoperazone reaches more than 90%, the purity reaches more than 99.6%, and the content of other impurities is less than 0.15%, and then used to prepare cefoperazone sodium, and cefoperazone sodium that fully meets the quality standards of cefoperazone sodium raw materials can be obtained.
[0051] The technical scheme and technical effects of the present invention are further described below in conjunction with embodiments and comparative examples.
[0052] In the following examples and comparative examples, the raw materials, reagents, etc. used were all commercially available.
[0053] In the following examples and comparative examples, unless otherwise specified, "%" refers to mass percentage.
[0054] In the following examples and comparative examples, the HPLC detection method is as follows:
[0055] Chromatographic column: Agilent ZORBAX Eclipse Plus C18 column, 4.6mm×150mm, 5μm or equivalent performance;
[0056] Mobile phase: triethylamine acetic acid solution (take 14 ml of triethylamine and 5.7 ml of glacial acetic acid, dilute to 100 ml with water, and shake well) - acetonitrile - water (1.2:150:850), and adjust the pH value to 3.0±0.2 with glacial acetic acid;
[0057] Detection wavelength: 254nm;
[0058] Flow rate: 1.2 mL / min;
[0059] Column temperature: 30℃.
[0060] Example 1
[0061] 1. Preparation of 7-TMCA
[0062] In a dry 500mL four-necked reaction bottle, add 70.0g of 1-methyl-5-mercapto-1,2,3,4-tetrazolyl, 80g of boron trifluoride acetonitrile, stir to dissolve, quickly add 16.0g of 7-ACA under nitrogen, control the temperature at 30±5°C, react for 1.5h, terminate the reaction, cool to 0-5°C, add 100g of purified water, and at the same time add 40% sodium hydroxide solution to adjust the pH to 3.0-4.0, keep warm at 0-5°C and stir to crystallize for 2h, filter, wash the filter cake with 30g of purified water and 30g of acetone in turn, and dry in vacuo at 50°C to obtain 18.2g of 7-TMCA with a molar yield of 94.3%.
[0063] 2. Preparation of Cefoperazone
[0064] 2.1.7-TMCA solution preparation
[0065] In a dry 250 mL four-necked reaction bottle, add 12.0 g 7-TMCA, 50 g acetonitrile, and 8.2 g N,O-bistrimethylsilylacetamide (BSA), stir to dissolve, cool to 0°C, and set aside;
[0066] 2.2. Preparation of HO-EPCP acyl chloride solution
[0067] In a dry 250mL four-necked reaction bottle, add 13.0g HO-EPCP, 60g N,N-dimethylacetamide, and 48g acetonitrile, cool to -25°C with stirring, add 6.3g phosphorus oxychloride dropwise (addition takes about 10min), and continue to keep warm for 0.5h after the addition is complete, and set aside;
[0068] 2.3. Preparation of Cefoperazone
[0069] Control the temperature at -25±5℃, add the HO-EPCP chloride solution dropwise into the 7-TMCA solution (addition takes about 0.5h), and continue to keep warm for 2h after the addition is complete. Add 35g purified water, 0.2g activated carbon and 0.1g sodium metabisulfite, decolorize for 0.5h, filter, wash with acetonitrile / purified water 20g (1:2), transfer the filtrate into a 1000mL reaction bottle, continue to add 100g purified water until crystals precipitate, keep warm for 2h, filter, and vacuum dry at 50℃ to obtain 21.8g of cefoperazone with a molar yield of 92.4%. HPLC test results are shown in Figure 1 The purity of cefoperazone is 99.708%, the impurity H content is 0.084%, and the contents of other impurities are all less than 0.15%.
[0070] Example 2
[0071] 1. Preparation of 7-TMCA
[0072] In a dry 500mL four-necked reaction bottle, add 105.0g of 1-methyl-5-mercapto-1,2,3,4-tetrazolyl, 120g of boron trifluoride acetonitrile, stir to dissolve, quickly add 24.0.g of 7-ACA under nitrogen, control the temperature at 30±5°C, react for 2.0h, terminate the reaction, cool to 0-5°C, add 150g of purified water, and at the same time add 40% sodium hydroxide solution to adjust the pH to 3.0-4.0, keep warm at 0-5°C and stir to crystallize for 2h, filter, wash the filter cake with 45g of purified water and 45g of acetone in turn, and dry in vacuo at 50°C to obtain 27.6g of 7-TMCA with a molar yield of 95.4%.
[0073] 2. Preparation of Cefoperazone
[0074] 2.1.7-TMCA solution preparation
[0075] In a dry 1000mL four-necked reaction bottle, add 24.0g 7-TMCA, 100g acetonitrile, and 16.5g N,O-bistrimethylsilylacetamide (BSA), stir to dissolve, cool to 0°C, and set aside;
[0076] 2.2. Preparation of HO-EPCP acyl chloride solution
[0077] In a dry 500mL four-necked reaction bottle, add HO-EPCP26.0g, N,N-dimethylacetamide 120g, acetonitrile 96g, cool to -25°C with stirring, add phosphorus oxychloride 12.6g dropwise (addition takes about 10min), and continue to keep warm for 0.5h after the addition is complete, and set aside;
[0078] 2.3. Preparation of Cefoperazone
[0079] Control the temperature at -25±5℃, add the HO-EPCP chloride solution dropwise into the 7-TMCA solution (addition takes about 0.5h), and continue to keep warm for 2h after the addition is complete. Add 70g purified water, 0.4g activated carbon and 0.2g sodium metabisulfite, decolorize for 0.5h, filter, wash with 40g acetonitrile / purified water (1:2), transfer the filtrate into a 1000mL reaction bottle, continue to add 200g purified water until crystals precipitate, keep warm for 2h, filter, and vacuum dry at 50℃ to obtain 44.1g of cefoperazone with a molar yield of 93.5%. HPLC test results are shown in Figure 2 The purity of cefoperazone is 99.645%, the impurity H content is 0.088%, and the contents of other impurities are all less than 0.15%.
[0080] Example 3
[0081] 1. Preparation of 7-TMCA
[0082] In a dry 500L reactor, 105.0kg of 1-methyl-5-mercapto-1,2,3,4-tetrazolyl was added, 120kg of boron trifluoride acetonitrile was stirred and dissolved, 24.0kg of 7-ACA was quickly added under nitrogen, the temperature was controlled at 30±5°C, the reaction was performed for 1.5h, the reaction was terminated, the temperature was lowered to 0-5°C, 150kg of purified water was added, and 40% sodium hydroxide solution was added dropwise to adjust the pH to 3.0-4.0, the temperature was kept at 0-5°C and stirred for crystallization for 2h, centrifuged, the filter cake was washed with 45kg of purified water and 45kg of acetone in turn, and vacuum dried at 50°C to obtain 27.3kg of 7-TMCA with a molar yield of 94.3%.
[0083] 2. Preparation of Cefoperazone
[0084] 2.1.7-TMCA solution preparation
[0085] In a dry 1000L reactor, add 24.0kg 7-TMCA, 100kg acetonitrile, and 16.5kg N,O-bistrimethylsilylacetamide (BSA), stir to dissolve, cool to 0°C, and set aside;
[0086] 2.2. Preparation of HO-EPCP acyl chloride solution
[0087] In a dry 500L reactor, add 26.0kg HO-EPCP, 120kg N,N-dimethylacetamide, and 96kg acetonitrile, cool to -25°C with stirring, add 12.6kg phosphorus oxychloride dropwise (addition takes about 10 minutes), and continue to keep warm for 0.5h after the addition is complete, and set aside;
[0088] 2.3. Preparation of Cefoperazone
[0089] Control the temperature at -25±5℃, add the HO-EPCP chloride solution dropwise into the 7-TMCA solution (addition takes about 0.5h), and continue to keep warm for 2h after the addition is complete. Add 70kg of purified water, 0.4kg of activated carbon and 0.2kg of sodium metabisulfite, decolorize for 0.5h, filter, wash with 40kg of acetonitrile / purified water (1:2), transfer the filtrate into a 1000L crystallization kettle, continue to add 200kg of purified water until crystals precipitate, keep warm for 2h, centrifuge, and vacuum dry at 50℃ to obtain 43.9kg of cefoperazone with a molar yield of 93.0%. HPLC test results are shown in Figure 3 The purity of cefoperazone is 99.752%, the impurity H content is 0.05%, and the contents of other impurities are all less than 0.15%.
[0090] Example 4
[0091] 1. Preparation of 7-TMCA
[0092] In a dry 1000L reactor, 210.0kg of 1-methyl-5-mercapto-1,2,3,4-tetrazolyl was added, 240kg of boron trifluoride acetonitrile was stirred and dissolved, 48.0kg of 7-ACA was quickly added under nitrogen, the temperature was controlled at 30±5°C, the reaction was carried out for 2.0h, the reaction was terminated, the temperature was cooled to 0-5°C, 300kg of purified water was added, and 40% sodium hydroxide solution was added dropwise to adjust the pH to 3.0-4.0, the temperature was kept at 0-5°C and stirred for crystallization for 2h, centrifuged, the filter cake was washed with 90kg of purified water and 90kg of acetone in turn, and vacuum dried at 50°C to obtain 55.3kg of 7-TMCA with a molar yield of 95.5%.
[0093] 2. Preparation of Cefoperazone
[0094] 2.1.7-TMCA solution preparation
[0095] In a dry 1000L reactor, add 48.0kg of 7-TMCA, 200kg of acetonitrile, and 33kg of N,O-bistrimethylsilylacetamide (BSA), stir to dissolve, cool to 0°C, and set aside;
[0096] 2.2. Preparation of HO-EPCP acyl chloride
[0097] In a dry 500L reactor, add 52.0kg HO-EPCP, 240kg N,N-dimethylacetamide, and 192kg acetonitrile, cool to -25°C with stirring, add 25.2kg phosphorus oxychloride dropwise (addition takes about 10 minutes), and continue to keep warm for 0.5h after the addition is complete, and set aside;
[0098] 2.3. Preparation of Cefoperazone
[0099] Control the temperature at -25±5℃, add the HO-EPCP chloride solution dropwise into the 7-TMCA solution (addition takes about 0.5h), and continue to keep warm for 2h after the addition is complete. Add 140kg of purified water, 0.8kg of activated carbon and 0.4kg of sodium metabisulfite, decolorize for 0.5h, filter, wash with 80kg of acetonitrile / purified water (1:2), transfer the filtrate into a 2000L crystallization kettle, continue to add 400kg of purified water until crystals precipitate, keep warm for 2h, centrifuge, and vacuum dry at 50℃ to obtain 87.3kg of cefoperazone with a molar yield of 92.5%. HPLC test results are shown in Figure 4 The purity of cefoperazone is 99.610%, the impurity H content is 0.075%, and the contents of other elements are all less than 0.15%.
[0100] Comparative Example 1
[0101] 1. Preparation of 7-TMCA
[0102] In a dry 500mL four-necked reaction bottle, add 70.0g of 1-methyl-5-mercapto-1,2,3,4-tetrazolyl, 80g of boron trifluoride acetonitrile, stir to dissolve, quickly add 16.0g of 7-ACA under nitrogen, control the temperature at 30±5°C, react for 1.5h, terminate the reaction, cool to 0-5°C, add 100g of purified water, and at the same time add 40% sodium hydroxide solution to adjust the pH to 3.0-4.0, keep warm at 0-5°C and stir to crystallize for 2h, filter, wash the filter cake with 30g of purified water and 30g of acetone in turn, and dry in vacuo at 50°C to obtain 18.2g of 7-TMCA with a molar yield of 94.3%.
[0103] 2. Preparation of Cefoperazone
[0104] 2.1.7-TMCA solution preparation
[0105] In a dry 250mL four-necked reaction bottle, add 12.0g 7-TMCA, 50g acetonitrile, and 8.2g N,O-bistrimethylsilylacetamide, stir to dissolve, cool to 0°C, and set aside;
[0106] 2.2. Preparation of HO-EPCP acyl chloride solution
[0107] In a dry 250mL four-necked reaction bottle, add HO-EPCP13.0g, N,N-dimethylacetamide 60g, acetonitrile 48g, cool to -25°C with stirring, add phosphorus oxychloride 6.3g dropwise (addition takes about 10min), and continue to keep warm for 0.5h after the addition is complete, and set aside;
[0108] 2.3. Preparation of Cefoperazone
[0109] Control the temperature at -25±5℃, add the 7-TMCA solution dropwise to the HO-EPCP chloride solution (addition takes about 0.5h), and continue to keep warm for 2h after the addition is complete. Add 35g purified water, 0.2g activated carbon and 0.1g sodium metabisulfite, decolorize for 0.5h, filter, wash with acetonitrile / purified water 20g (1:2), transfer the filtrate to a 1000mL reaction bottle, continue to add 100g purified water until crystals precipitate, keep warm for 2h, filter, and vacuum dry at 50℃ to obtain 21.5g of cefoperazone with a molar yield of 91.1%. HPLC test results are shown in Figure 5 , the purity of cefoperazone is 99.162%, and the impurity H content is 0.535%.
[0110] Comparative Example 2
[0111] 1. Preparation of 7-TMCA
[0112] In a dry 500mL four-necked reaction bottle, add 98.0g of 1-methyl-5-mercapto-1,2,3,4-tetrazolyl and 112g of boron trifluoride acetonitrile, stir and dissolve, quickly add 22.4g of 7-ACA under nitrogen, control the temperature at 30±5°C, react for 2.0h, terminate the reaction, cool to 0-5°C, add 140g of purified water dropwise, and at the same time add 40% sodium hydroxide solution dropwise to adjust the pH to 3.0-4.0, keep warm at 0-5°C and stir to crystallize for 2h, filter, wash the filter cake with 42g of purified water and 42g of acetone in turn, and dry in vacuo at 50°C to obtain 25.5g of 7-TMCA with a molar yield of 94.4%.
[0113] 2. Preparation of Cefoperazone
[0114] 2.1.7-TMCA solution preparation
[0115] In a dry 250 mL four-necked reaction bottle, add 24.0 g of 7-TMCA, 100 g of acetonitrile, and 16.5 g of N,O-bistrimethylsilylacetamide, stir to dissolve, cool to 0°C, and set aside;
[0116] 2.2. Preparation of HO-EPCP acyl chloride solution
[0117] In a dry 1000mL four-necked reaction bottle, add HO-EPCP 26.0g, N,N-dimethylacetamide 120g, acetonitrile 96g, cool to -25°C with stirring, add phosphorus oxychloride 12.6g dropwise (addition takes about 10min), and continue to keep warm for 0.5h after the addition is complete, and set aside;
[0118] 2.3. Preparation of Cefoperazone
[0119] Control the temperature at -25±5℃, add the 7-TMCA solution dropwise to the HO-EPCP chloride solution (addition takes about 0.5h), and continue to keep warm for 2h after the addition is complete. Add 70g purified water, 0.4g activated carbon and 0.2g sodium metabisulfite, decolorize for 0.5h, filter, wash with 40g acetonitrile / purified water (1:2), transfer the filtrate to a 1000mL reaction bottle, continue to add 200g purified water until crystals precipitate, keep warm for 2h, filter, and vacuum dry at 50℃ to obtain 44.1g of cefoperazone with a molar yield of 93.5%. HPLC test results are shown in Figure 6 , cefoperazone 99.427%, impurity H content 0.363%.
[0120] The above detailed description of the present invention is intended to enable persons familiar with the art to understand the contents of the present invention and implement them. It does not limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing cefoperazone, characterized in that: The preparation method of cefoperazone comprises: Providing 7-TMCA solution; Providing HO-EPCP acyl chloride solution; At -30 to -20°C, the HO-EPCP acyl chloride solution is added dropwise to the 7-TMCA solution. After the addition is complete, the mixture is kept warm at -30 to -20°C to obtain a reaction solution containing cefoperazone.
2. The method for preparing cefoperazone according to claim 1, characterized in that: The molar ratio of 7-TMCA in the 7-TMCA solution to HO-EPCP in the HO-EPCP acyl chloride solution is 1:(1.05-1.15).
3. The method for preparing cefoperazone according to claim 1, characterized in that: The preparation method of the HO-EPCP acyl chloride solution is as follows: phosphorus oxychloride is added dropwise to a solution consisting of HO-EPCP, N,N-dimethylacetamide and acetonitrile at -30 to -20°C, and after the addition is completed, the HO-EPCP acyl chloride solution is obtained by heat-preserving and reacting at -30 to -20°C.
4. The method for preparing cefoperazone according to claim 3, characterized in that: The molar ratio of HO-EPCP to phosphorus oxychloride is 1:(1.05-1.08); and / or, the mass ratio of the HO-EPCP to N,N-dimethylacetamide and acetonitrile is 1:(2-5):(2-5); And / or, in the method for preparing the HO-EPCP acyl chloride solution, the insulation reaction time is 0.4 to 0.6 h.
5. The method for preparing cefoperazone according to claim 1, characterized in that: The 7-TMCA solution is prepared by mixing 7-TMCA, acetonitrile and N,O-bistrimethylsilylacetamide.
6. The method for preparing cefoperazone according to claim 1, characterized in that: The molar ratio of 7-TMCA to N,O-bistrimethylsilylacetamide in the 7-TMCA solution is 1:(1.1-1.4), and / or the mass ratio of 7-TMCA to acetonitrile is 1:(4-8).
7. The method for preparing cefoperazone according to claim 1, characterized in that: The insulation reaction time is 1.5 to 2.5 hours.
8. The method for preparing cefoperazone according to claim 1, characterized in that: The preparation method of cefoperazone also includes post-treatment, which includes: first adding purified water, activated carbon and sodium metabisulfite to the reaction solution containing cefoperazone for decolorization, then filtering, washing with a mixture of acetonitrile and purified water, adding water to the filtrate for crystallization, growing crystals, separating solids, and vacuum drying the solids to obtain cefoperazone.
9. The method for preparing cefoperazone according to claim 1, characterized in that: The preparation method of cefoperazone also includes the step of preparing 7-TMCA by reacting 1-methyl-5-mercapto-1,2,3,4-tetrazolyl with 7-ACA in boron trifluoride acetonitrile at 25-35° C. under the protection of inert gas.
10. The method for preparing cefoperazone according to claim 9, characterized in that: The reaction time at 25-35° C. is 1-2 hours. After the reaction is completed, the temperature is lowered to 0-5° C., purified water is added and the pH is adjusted to 3.0-4.0, and crystallization is stirred at 0-5° C., filtered, and the filter cake is washed with purified water and acetone in turn, and dried to obtain the 7-TMCA.
Citation Information
Patent Citations
Synthesizing method for cephalosporin compound
CN102372728A
Novel method for synthesizing cefoperazone sodium compound
CN102372729A
Synthesis method of cefoperazone acid
CN102532168A
Preparation of penicillins and and chphalosporins
JP1978044584A
Broad-spectrum cephalosporin antibiotics resistant to beta-lactamase - 7-(alpha-(4pethyl-2,3-dioxo-piperazinocarbonylamino)-para-hydroxy- phenylacetamido)-ceph-3-em-4-carboxylic acids
NL7600372A
